Epigenetic Therapeutic Strategies to Target Molecular and Cellular Heterogeneity in Pancreatic Cancer
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Epigenetic Therapeutic Strategies to Target Molecular and Cellular Heterogeneity in Pancreatic Cancer
Authors
Keywords
-
Journal
Visceral Medicine
Volume 38, Issue 1, Pages 11-19
Publisher
S. Karger AG
Online
2021-11-20
DOI
10.1159/000519859
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Transcription phenotypes of pancreatic cancer are driven by genomic events during tumor evolution
- (2020) Michelle Chan-Seng-Yue et al. NATURE GENETICS
- Microenvironmental Determinants of Pancreatic Cancer
- (2020) Elisabeth Hessmann et al. PHYSIOLOGICAL REVIEWS
- HNF4A and GATA6 Loss Reveals Therapeutically Actionable Subtypes in Pancreatic Cancer
- (2020) Holly Brunton et al. Cell Reports
- 5-Azacytidine Potentiates Anti-tumor Immunity in a Model of Pancreatic Ductal Adenocarcinoma
- (2020) Nancy D. Ebelt et al. Frontiers in Immunology
- Depletion of Macrophages Improves Therapeutic Response to Gemcitabine in Murine Pancreas Cancer
- (2020) Soeren M. Buchholz et al. Cancers
- Impact of HDAC Inhibitors on Protein Quality Control Systems: Consequences for Precision Medicine in Malignant Disease
- (2020) Linda Anna Michelle Kulka et al. Frontiers in Cell and Developmental Biology
- EZH2 regulates pancreatic cancer subtype identity and tumor progression via transcriptional repression of GATA6
- (2020) Shilpa Patil et al. CANCER RESEARCH
- The Immune Microenvironment in Pancreatic Cancer
- (2020) Magdalena Huber et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Aggressive PDACs show hypomethylation of repetitive elements and the execution of an intrinsic IFN program linked to a ductal cell-of-origin
- (2020) Elisa Espinet et al. Cancer Discovery
- Transcriptional control of subtype switching ensures adaptation and growth of pancreatic cancer
- (2019) Christina R Adams et al. eLife
- Emerging epigenomic landscapes of pancreatic cancer in the era of precision medicine
- (2019) Gwen Lomberk et al. Nature Communications
- Loss of KDM6A Activates Super-Enhancers to Induce Gender-Specific Squamous-like Pancreatic Cancer and Confers Sensitivity to BET Inhibitors
- (2018) Jaclyn Andricovich et al. CANCER CELL
- Distinct epigenetic landscapes underlie the pathobiology of pancreatic cancer subtypes
- (2018) Gwen Lomberk et al. Nature Communications
- Stromal biology and therapy in pancreatic cancer: ready for clinical translation?
- (2018) Albrecht Neesse et al. GUT
- Stratification of Pancreatic Ductal Adenocarcinomas Based on Tumor and Microenvironment Features
- (2018) Francesco Puleo et al. GASTROENTEROLOGY
- DeltaNp63-dependent super enhancers define molecular identity in pancreatic cancer by an interconnected transcription factor network
- (2018) Feda H. Hamdan et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- TP63-Mediated Enhancer Reprogramming Drives the Squamous Subtype of Pancreatic Ductal Adenocarcinoma
- (2018) Tim D.D. Somerville et al. Cell Reports
- Entinostat Converts Immune-Resistant Breast and Pancreatic Cancers into Checkpoint-Responsive Tumors by Reprogramming Tumor-Infiltrating MDSCs
- (2018) Brian J. Christmas et al. Cancer Immunology Research
- Context-Dependent Epigenetic Regulation of Nuclear Factor of Activated T Cells 1 in Pancreatic Plasticity
- (2017) Nai-Ming Chen et al. GASTROENTEROLOGY
- Fibroblast drug scavenging increases intratumoural gemcitabine accumulation in murine pancreas cancer
- (2017) E Hessmann et al. GUT
- The MLL1-H3K4me3 Axis-Mediated PD-L1 Expression and Pancreatic Cancer Immune Evasion
- (2017) Chunwan Lu et al. JNCI-Journal of the National Cancer Institute
- Precision medicine in breast cancer: reality or utopia?
- (2017) Ali Bettaieb et al. Journal of Translational Medicine
- The MLL1-H3K4me3 Axis-Mediated PD-L1 Expression and Pancreatic Cancer Immune Evasion
- (2017) Chunwan Lu et al. JNCI-Journal of the National Cancer Institute
- Epigenetic treatment of pancreatic cancer: is there a therapeutic perspective on the horizon?
- (2016) Elisabeth Hessmann et al. GUT
- Genomic analyses identify molecular subtypes of pancreatic cancer
- (2016) Peter Bailey et al. NATURE
- Histone deacetylase inhibitors provoke a tumor supportive phenotype in pancreatic cancer associated fibroblasts
- (2016) Andrew H. Nguyen et al. Oncotarget
- Stromal remodeling by the BET bromodomain inhibitor JQ1 suppresses the progression of human pancreatic cancer
- (2016) Keisuke Yamamoto et al. Oncotarget
- A novel epigenetic mechanism regulating hyaluronan production in pancreatic cancer cells
- (2015) Shiro Kohi et al. CLINICAL & EXPERIMENTAL METASTASIS
- Lung Cancer in the Era of Precision Medicine
- (2015) K. Politi et al. CLINICAL CANCER RESEARCH
- Stromal biology and therapy in pancreatic cancer: a changing paradigm
- (2015) Albrecht Neesse et al. GUT
- Whole genomes redefine the mutational landscape of pancreatic cancer
- (2015) Nicola Waddell et al. NATURE
- What are super-enhancers?
- (2015) Sebastian Pott et al. NATURE GENETICS
- Virtual microdissection identifies distinct tumor- and stroma-specific subtypes of pancreatic ductal adenocarcinoma
- (2015) Richard A Moffitt et al. NATURE GENETICS
- Combined inhibition of BET family proteins and histone deacetylases as a potential epigenetics-based therapy for pancreatic ductal adenocarcinoma
- (2015) Pawel K Mazur et al. NATURE MEDICINE
- The BET bromodomain inhibitor JQ1 suppresses growth of pancreatic ductal adenocarcinoma in patient-derived xenograft models
- (2015) P L Garcia et al. ONCOGENE
- Metabolite profiling stratifies pancreatic ductal adenocarcinomas into subtypes with distinct sensitivities to metabolic inhibitors
- (2015) Anneleen Daemen et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- A mutational signature in gastric cancer suggests therapeutic strategies
- (2015) Ludmil B. Alexandrov et al. Nature Communications
- Augmenting Antitumor Immune Responses with Epigenetic Modifying Agents
- (2015) Erika Héninger et al. Frontiers in Immunology
- Tissue-Resident Macrophage Enhancer Landscapes Are Shaped by the Local Microenvironment
- (2014) Yonit Lavin et al. CELL
- Environment Drives Selection and Function of Enhancers Controlling Tissue-Specific Macrophage Identities
- (2014) David Gosselin et al. CELL
- BET Bromodomain Inhibitors Block Growth of Pancreatic Cancer Cells in Three-Dimensional Collagen
- (2014) V. Sahai et al. MOLECULAR CANCER THERAPEUTICS
- Targeting bromodomains: epigenetic readers of lysine acetylation
- (2014) Panagis Filippakopoulos et al. NATURE REVIEWS DRUG DISCOVERY
- Master Transcription Factors and Mediator Establish Super-Enhancers at Key Cell Identity Genes
- (2013) Warren A. Whyte et al. CELL
- Hypomethylating Therapy in an Aggressive Stroma-Rich Model of Pancreatic Carcinoma
- (2012) R. Shakya et al. CANCER RESEARCH
- EZH2 couples pancreatic regeneration to neoplastic progression
- (2012) J. Mallen-St. Clair et al. GENES & DEVELOPMENT
- Hyaluronan impairs vascular function and drug delivery in a mouse model of pancreatic cancer
- (2012) Michael A Jacobetz et al. GUT
- Pancreatic cancer genomes reveal aberrations in axon guidance pathway genes
- (2012) Andrew V. Biankin et al. NATURE
- Gli Proteins in Development and Disease
- (2011) Chi-chung Hui et al. Annual Review of Cell and Developmental Biology
- Subtypes of pancreatic ductal adenocarcinoma and their differing responses to therapy
- (2011) Eric A Collisson et al. NATURE MEDICINE
- Selective inhibition of BET bromodomains
- (2010) Panagis Filippakopoulos et al. NATURE
- Targeting histone deacetylases in pancreatic ductal adenocarcinoma
- (2009) Günter Schneider et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now